Oxidative stress induced by Cremophor EL is not accompanied by changes in NF-κB activation or iNOS expression

被引:24
作者
Belen Gutierrez, Maria
San Miguel, Beatriz
Villares, Carmen
Gonzalez Gallego, Javier
Jesus Tunon, Maria [1 ]
机构
[1] Univ Leon, Dept Physiol, E-24071 Leon, Spain
[2] Hosp Leon, Pharm Unit, Leon 24071, Spain
关键词
Cremophor EL; glutathione; oxidative stress; nitric oxide; nuclear factor kappa B;
D O I
10.1016/j.tox.2006.02.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of polyoxyethylenglycerol triricinoleate 35 (Cremophor EL, CrEL) on markers of oxidative stress, nuclear factor kappa B (NF-kappa B) activation and inducible nitric oxide synthase (NOS) expression were studied in the liver of male Wistar rats. Animals were randomly divided into three groups. Group Cr1 received, i.p., CrEL at 0.046 ml/kg daily for 7 days, group Cr2 received CrEL at 0.33 ml/kg and the controls were injected with CrEL vehicle (saline solution with 25% ethanol). Both alanine transaminasc (ALT) and aspartate transaminase (AST) serum activities were significantly increased in the Cr2 group (+16% and +25%, respectively). AST activity was also higher in the Cr1 group when compared to control animals (+20%). The cytosolic concentration of thiobarbituric acid reactive substances (TBARS) increased in both groups of rats receiving CrEL (Cr1: +24%; Cr2: +33%). Reduced glutathione (GSH) concentration was not significantly modified at any of the CrEL doses, but both the hepatic concentration of oxidised glutathione (GSSG) (Cr1: +37%; Cr2: +84%) and the GSH/GSSG ratio (Cr1: -21%; Cr2: -45%) were significantly modified. CrEL induced no significant NF-kappa B activation, changes in p50 and p65 NF-kappa B subunits or induction of NOS protein. Data obtained indicate that although high doses of CrEL cause oxidative stress, this is not enough to induce changes in NF-kappa B activation or NOS expression. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 42 条
[1]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[2]   Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut [J].
Bardelmeijer, HA ;
Ouwehand, M ;
Malingré, MM ;
Schellens, JHM ;
Beijnen, JH ;
van Tellingen, O .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (02) :119-125
[3]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[4]   Oxidative stress and nuclear factor-κB activation -: A reassessment of the evidence in the light of recent discoveries [J].
Bowie, A ;
O'Neill, LAJ .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (01) :13-23
[5]   EFFECTS OF OXIDANTS AND ANTIOXIDANTS ON NUCLEAR FACTOR KAPPA-B ACTIVATION IN 3 DIFFERENT CELL-LINES - EVIDENCE AGAINST A UNIVERSAL HYPOTHESIS INVOLVING OXYGEN RADICALS [J].
BRENNAN, P ;
ONEILL, LAJ .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1260 (02) :167-175
[6]  
Csoka K, 1997, CANCER-AM CANCER SOC, V79, P1225, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1225::AID-CNCR23>3.0.CO
[7]  
2-0
[8]   REVERSAL OF MULTIDRUG-RESISTANCE PHENOTYPE BY SURFACTANTS - RELATIONSHIP TO MEMBRANE LIPID FLUIDITY [J].
DUDEJA, PK ;
ANDERSON, KM ;
HARRIS, JS ;
BUCKINGHAM, L ;
COON, JS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (01) :309-315
[9]  
GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369
[10]   Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation [J].
Gelderblom, H ;
Verweij, J ;
Nooter, K ;
Sparreboom, A .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) :1590-1598